165 related articles for article (PubMed ID: 10665560)
21. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
22. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation.
Peddi VR; Wiseman A; Chavin K; Slakey D
Transplant Rev (Orlando); 2013 Oct; 27(4):97-107. PubMed ID: 23932018
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of application of sirolimus with dose-reduced or discontinued cyclosporine A for prevention of acute rejection after kidney transplantation].
Lin J; Tang YW; Sun W; DU LD; Tian Y
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1319-21. PubMed ID: 20092728
[TBL] [Abstract][Full Text] [Related]
24. FK 506 for liver, kidney, and pancreas transplantation.
Starzl TE; Todo S; Fung J; Demetris AJ; Venkataramman R; Jain A
Lancet; 1989 Oct; 2(8670):1000-4. PubMed ID: 2478846
[TBL] [Abstract][Full Text] [Related]
25. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
26. De novo use of low-dose tacrolimus and sirolimus in liver transplantation.
Peltekian K; McAlister VC; Colohan S; Gao Z; Salazar AB; Bitter-Suermann H; MacDonald AS
Transplant Proc; 2001; 33(1-2):1341. PubMed ID: 11267318
[No Abstract] [Full Text] [Related]
27. Sirolimus for solid organ transplantation in children.
Gupta P; Kaufman S; Fishbein TM
Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of sirolimus in renal transplantation: an update.
Chueh SC; Kahan BD
Transpl Int; 2005 Mar; 18(3):261-77. PubMed ID: 15730485
[TBL] [Abstract][Full Text] [Related]
29. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
30. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
Hougardy JM; Broeders N; Kianda M; Massart A; Madhoun P; Le Moine A; Hoang AD; Mikhalski D; Wissing KM; Abramowicz D
Transplantation; 2011 Mar; 91(5):566-9. PubMed ID: 21192316
[TBL] [Abstract][Full Text] [Related]
31. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
32. Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus.
Chen H; Peng J; Luo H; Loubeau M; Wan X; Xu D; Qi S; Vu MD; Daloze P; Fitzsimmons WE; Bekersky I; Peets J; Sehgal SN; Wu J
Transplantation; 2000 Apr; 69(8):1555-61. PubMed ID: 10836361
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients.
Maramattom BV; Wijdicks EF
Neurology; 2004 Nov; 63(10):1958-9. PubMed ID: 15557524
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Peddi VR; Demmy AM; Munda R; Alexander JW; First MR
Transplant Proc; 1998 Mar; 30(2):509-11. PubMed ID: 9532151
[No Abstract] [Full Text] [Related]
35. Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.
El-Sabrout R; Weiss R; Butt F; Delaney V; Qadir M; Hanson P; Butt K
Transplant Proc; 2002 Aug; 34(5):1942-3. PubMed ID: 12176636
[No Abstract] [Full Text] [Related]
36. Tolerogenic immunosuppression for organ transplantation.
Starzl TE; Murase N; Abu-Elmagd K; Gray EA; Shapiro R; Eghtesad B; Corry RJ; Jordan ML; Fontes P; Gayowski T; Bond G; Scantlebury VP; Potdar S; Randhawa P; Wu T; Zeevi A; Nalesnik MA; Woodward J; Marcos A; Trucco M; Demetris AJ; Fung JJ
Lancet; 2003 May; 361(9368):1502-10. PubMed ID: 12737859
[TBL] [Abstract][Full Text] [Related]
37. Comment: delayed wound healing with sirolimus after liver transplant.
Mathis AS
Ann Pharmacother; 2003 Mar; 37(3):453. PubMed ID: 12639183
[No Abstract] [Full Text] [Related]
38. One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation.
di Francesco F; Cautero N; Vincenzi P; Nicolini D; De Luca S; Vecchi A; Garelli P; Martorelli G; Gentili M; Risaliti A; Boemi M
Transplantation; 2008 Oct; 86(8):1146-7. PubMed ID: 18946356
[No Abstract] [Full Text] [Related]
39. Sirolimus permits steroid withdrawal from a cyclosporine regimen.
Mahalati K; Kahan BD
Transplant Proc; 2001; 33(1-2):1270. PubMed ID: 11267287
[No Abstract] [Full Text] [Related]
40. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation.
Becker G; Witzke O; Friedrich J; Albrecht KH; Wagner K; Philipp T; Heemann U
Transpl Int; 1997; 10(1):51-4. PubMed ID: 9002152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
